Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pneumonia in the elderly.

C Carbon1

  • 1Service de Médicine Interne, Hôpital Bichat, Paris, France.

International Journal of Antimicrobial Agents
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Pneumonia is a major infectious cause of death, especially in the elderly. Treatment for community-acquired pneumonia is often empirical, with invasive tests reserved for severe cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lack of correlation between hydrogen peroxide production and nitric oxide production by cultured rabbit articular chondrocytes treated with fluoroquinolone antimicrobial agents.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

Clinical and bacteriologic efficacy of telithromycin in patients with bacteremic community-acquired pneumonia.

Respiratory medicine·2005
Same author

Medecine et maladies infectieuses·2005
Same author

Medecine et maladies infectieuses·2005
Same author

[Ecological risk of antibiotic use: consequences for new molecule evaluation].

Medecine et maladies infectieuses·2005
Same author

[Link between resistance and failure in community-acquired respiratory infections].

Medecine et maladies infectieuses·2005
Same journal

Strain-dependent variability in pharmacodynamic interactions for phage-antibiotic combinations in Pseudomonas aeruginosa.

International journal of antimicrobial agents·2026
Same journal

Carbapenem-resistant Enterobacterales across the UK: a nationwide study of carbapenemase testing and novel antimicrobial activity.

International journal of antimicrobial agents·2026
Same journal

Kidney Injury, Dialysis, and Mortality with Vancomycin Plus Piperacillin-Tazobactam or Cefepime.

International journal of antimicrobial agents·2026
Same journal

Ceftaroline pharmacokinetics on ECMO, a pediatric case report.

International journal of antimicrobial agents·2026
Same journal

In reply to the Letter to Editor regarding "Comment on "Development and validation of a predictive model for profiling antibiotic resistance phenotypes of Acinetobacter baumannii strains via clinical MALDI-TOF mass spectra: A multicenter study".

International journal of antimicrobial agents·2026
Same journal

Comment on "Targeting the human protein disulfide isomerase A3 as a broad-spectrum antiviral approach against human respiratory viruses".

International journal of antimicrobial agents·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Geriatrics
  • Pulmonology

Background:

  • Pneumonia is a leading cause of death from infectious disease in the elderly.
  • Streptococcus pneumoniae is the primary cause of community-acquired pneumonia.
  • Aspiration pneumonia is common in patients with neuromuscular disease.

Purpose of the Study:

  • To review current approaches to pneumonia diagnosis and treatment.
  • To highlight the importance of empirical therapy for community-acquired pneumonia.
  • To discuss treatment strategies for aspiration pneumonia and nosocomial infections.

Main Methods:

  • Review of existing literature on pneumonia epidemiology and treatment.
  • Analysis of common etiological agents and risk factors.

Related Experiment Videos

  • Discussion of therapeutic guidelines for different pneumonia types.

    • Main Results:

    • Community-acquired pneumonia often requires empirical broad-spectrum antibiotic coverage.
    • Invasive diagnostic tests are indicated for severe community-acquired pneumonia cases.
    • Aspiration pneumonia treatment may involve beta-lactam/beta-lactamase inhibitor combinations.

    Conclusions:

    • Prompt and appropriate treatment is crucial for managing pneumonia, particularly in vulnerable populations.
    • Tailoring therapy based on bacterial susceptibility is key for nosocomial infections.
    • Understanding causative agents and risk factors guides effective pneumonia management.